Medication info
Pobigle Tablet 10/100 mg

Pobigle Tablet 10/100 mg

Prescription medicationTablet
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tabletSitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Bright yellowish-brown oval film-coated tablets
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202301100 · Approved 2023.03.31 · Insurance code 647805570

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes
Who uses it
Adults
Adult dosage
This medicine may be administered to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg as 1 tablet once daily, regardless of meals. The tablet should be swallowed whole. The efficacy and safety of this medicine vary depending on renal function. It is recommended that renal function be assessed before treatment and periodically thereafter. No dosage adjustment is required when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. Do not administer this medicine when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. No dosage adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes

View approved original text

This medication is used to assist in blood sugar control for patients with type 2 diabetes. It specifically helps patients taking both sitagliptin and dapagliflozin to effectively improve blood sugar levels when combined with diet and exercise therapy. This facilitates smoother blood sugar control, which is significant for health management.

Dosage and Administration

Adult dosage

This medicine may be administered to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg as 1 tablet once daily, regardless of meals. The tablet should be swallowed whole. The efficacy and safety of this medicine vary depending on renal function. It is recommended that renal function be assessed before treatment and periodically thereafter. No dosage adjustment is required when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. Do not administer this medicine when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. No dosage adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Precautions

This medication contains sitagliptin and dapagliflozin, which are used in the treatment of diabetes. First, the sitagliptin component may rarely cause severe allergic reactions such as anaphylaxis, angioedema, or severe skin conditions after administration, therefore if allergic symptoms occur within the first three months of treatment, it must be discontinued immediately and a doctor should be consulted. Additionally, sitagliptin may have the potential for pancreatitis, so it is important to monitor for abdominal pain or dyspeptic symptoms during treatment and discontinue if necessary. Next, the dapagliflozin component may cause hypotension or renal impairment related to decreased body fluid volume; thus, particularly patients with renal impairment or the elderly should thoroughly check their fluid status and kidney function before taking this medication, and monitor their symptoms during use. This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or those on dialysis and caution is necessary if allergic to Tartrazine (yellow No. 4). During treatment, hypoglycemic symptoms may occur, so dosage adjustments may be necessary when used with insulin or sulfonylureas to reduce the risk of hypoglycemia. Furthermore, dapagliflozin may increase the risk of genital infections and urinary tract infections, so immediate treatment is required if infection symptoms occur. Pregnant or breastfeeding women should avoid using this medication, especially during breastfeeding as the drug can be transmitted through breast milk and affect the baby. The elderly may have impaired kidney function and should undergo regular kidney function tests and carefully monitor their fluid status. In the case of an overdose, there are no specific antidotes, so receiving appropriate treatment according to symptoms is essential, and blood dialysis may be considered if necessary. Finally, caution is needed during driving or operating machinery as there may be risks of hypoglycemia during the use of this medication. Please ensure to consult with a doctor or pharmacist before and during use of this medication for safe administration.

Side effects

Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, decrease in fluid volume, renal dysfunction, hypoglycemia, vulvovaginitis, balanitis, genital infections, urinary tract infections, fungal infections, perineal necrosis, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, vulvar pruritus, genital pruritus, elevated hematocrit, increased serum creatinine, dyslipidemia, rash, pneumonia, pulmonary tuberculosis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, elevated liver enzymes, acute renal failure, severe and disability-associated arthralgia, vesiculobullous dermatitis, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, dyspepsia, nausea, diarrhea, vomiting, headache, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, somnolence, headache, nasopharyngitis, upper respiratory tract infection, peripheral edema, itching, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, dry eye, ocular pain, retinal disorders, vision changes, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, hemoptysis, sputum, obstructive sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral cooling, varicose veins, vascular headache, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus, taste disturbances, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, coma, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, chest pain, fatigue, pain, hunger, vaginal discharge, menstrual irregularity, vaginal discharge, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, hair loss, dermatitis, xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcers, sweating abnormalities eczema, coin-shaped eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, increased appetite, microalbuminuria, abdominal pressure urinary incontinence, urinary hesitancy, urinary stones, abnormal urination, urgency, increased serum lactate, lymphocytopenia, weight gain, increased serum triglycerides, increased serum lactate, increased serum creatinine, elevated blood urea, weight loss, palpitations, anxiety disorder, nocturia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Bright yellowish-brown oval film-coated tablets

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.